BNET Industries

Market Cap:$89.2M
Last Fiscal Year Sales:$7.1M
  • Public
  • US
Dow Jones Description

Neoprobe Corporation is focused on developing and commercializing innovative biomedical products that meet the critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. Our primary area of focus is in improving cancer surgery outcomes by using our market-leading gamma detection devices in combination with radiopharmaceutical agents also referred to as "tracing" or "targeting" agents. We have also recently formed another majority-owned subsidiary, Cira Biosciences, Inc., to explore the development and commercialization of an activated cellular therapy technology that has shown promising early stage patient-specific treatment potential in oncology, viral (HIV/AIDS and hepatitis) and autoimmune diseases.

CEO and President
David C. Bupp
Number of Employees 25
Contact Information

425 Metro Pl N Ste 300

Dublin, Ohio 43017

neoprobe.com

(614) 793-7500

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

Recent Events

  • Neoprobe books $25 million loss in Q3

    11/05/09 - Financial Announcement - View Story

  • Laureate Pharma to Manufacture Neoprobe's MAb Product

    10/12/09 - Joint Venture / Alliance - View Story

  • Neoprobe finds manufacturer for Rigscan

    9/08/09 - Financial Announcement - View Story

  • Laureate Pharma and Neoprobe Corporation Announce Manufacturing Alliance - Laureate to Manufacture Neoprobe's RIGScanR CR...

    9/08/09 - Licensing / Contract - View Story

  • Neoprobe continues losses in Q2

    8/16/09 - Financial Announcement - View Story

  • Neoprobe Announces Second Quarter Results

    8/11/09 - Financial Announcement - View Story

  • Neoprobe to Receive $3.5 Million from Montaur Warrant Exercise RIGS Biologic Development Initiative Commenced

    7/27/09 - New Investment - View Story

  • Taglich Brothers Initiates Coverage of Neoprobe Corporation

    7/23/09 - Bond / Stock Rating - View Story

News & Analysis

neoprobe corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
David C. Bupp CEO and President
Brent L. Larson Vice President Finance and Cfo
Anthony K. Blair Vice President, Manufacturing Operations
Carl M. Bosch Vice President, Research and Development
Douglas L. Rash Vice President, Marketing
Rodger A. Brown Vice President
Richard Orahood Neoprobe's Medical Director
John S. Christie Secretary

Board of Directors

Name (plus bio) Position
Carl J. Aschinger Chairman of the Board of Directors
Fred B. Miller Chairman
Julius R. Krevans Chairman
Kirby I. Bland Chairman
Gordon A. Troup Board of Directors
J Carl Jr Board of Directors
J. Frank Whitley Jr. Board of Directors
Nancy E. Katz Board of Directors
Owen E. Johnson Board of Directors
Reuven Avital Board of Directors

Organization Position Status
Neoprobe Corporation CEO and President Current
Neoprobe Corporation Board of Directors Current
Neoprobe Corporation President and Director Former
Ohio Wesleyan University B.A. Degree In Economics Former

Organization Position Status
Neoprobe Corporation Vice President Finance and Cfo Current

Organization Position Status
Neoprobe Corporation Vice President, Manufacturing Operations Current
Enpath Medical, Inc. Vice President, Manufacturing Operations Former
Fisher Body Corporation Former
Cleveland State University B.B.A. Degree In Management Former

Organization Position Status
Neoprobe Corporation Vice President, Research and Development Current

Organization Position Status
Neoprobe Corporation Vice President, Marketing Current
Neoprobe Corporation Director Former

Organization Position Status
Neoprobe Corporation Vice President Current

Organization Position Status
Neoprobe Corporation Neoprobe's Medical Director Current

Organization Position Status
Worthington Industries, Inc. President Current
Neoprobe Corporation Secretary Current
Crane Group Limited Advisory Board Member Current
The Fishel Company Inc. Advisory Board Member Current
Bank One, N.A. Advisory Board Member Current
Miami University Board of Directors Current
Worthington Cylinder Corporation President Former
JMAC Inc. President Former
Worthington Industries, Inc. Chief Financial Officer Current
Worthington Industries, Inc. Founder Former
SPX Corporation Officer Former
Worthington Industries, Inc. Chairman Emeritus Former
SPX Corporation Director Former
Neoprobe Corporation Secretary Former
Franklin University Board Member Former
Worthington Industries, Inc. Director Current
Miami University Bachelor of Science Degree In Business Administration Former

Array

Organization Position Status
Neoprobe Corporation Chairman of the Board of Directors Current
Csc Worldwide Chairman Current
Neoprobe Corporation Board of Directors Current
Pinnacle Data Systems, Inc. Board of Directors Current

Fred B. Miller has served as a director of our Company since January 2002. Mr. Miller serves as Chairman of the Audit committee. Mr. Miller is the President and Chief Operating Officer of Seicon, Limited, a privately held company that specializes in developing, applying and licensing technology to reduce seismic and mechanically induced vibration. Mr. Miller also serves on the boards of two other privately-held companies. Until his retirement in 1995, Mr. Miller had been with Price Waterhouse LLP since 1962. Mr. Miller is a Certified Public Accountant, a member of the American Institute of Certified Public Accountants (AICPA), a past member of the Council of the AICPA and a member and past president of the Ohio Society of Certified Public Accountants. He also has served on the boards or advisory committees of several universities and not-for-profit organizations. Mr. Miller has a B.S. degree in Accounting from the Ohio State University.

Organization Position Status
American Institute of Certified Public Accountants Member Current
Neoprobe Corporation Chairman Current
Neoprobe Corporation Board of Directors Current
American Institute of Certified Public Accountants Member Current
The Ohio State University B.S. Degree In Accounting Former

Company since May 1994 and as Chairman of the Board of Directors of our Company since February 1999. Dr. Krevans served as Chancellor of the University of California, San Francisco from July 1982 until May 1993. Prior to his appointment as Chancellor, Dr. Krevans served as a Professor of Medicine and Dean of the School of Medicine at the University of California, San Francisco from 1971 to 1982. Dr. Krevans is a member of the Institute of Medicine, National Academy of Sciences, and led its committee for the National Research Agenda on Aging until 1991. Dr. Krevans also serves on the Board of Directors and the compensation committee of the Board of Directors of Calypte Biomedical corporation (Calypte), a publicly held corporation. Dr.Krevans has a B.S. degree and a M.D. degree, both from New York University.

Organization Position Status
National Academy of Sciences Member Current
Neoprobe Corporation Chairman Current
Neoprobe Corporation Board of Directors Current
Calypte Biomedical Corporation Board of Directors Current
University of California, San Francisco Director of International Medical Care Former
University of California, San Francisco Professor of Medicine Former
New York University M.D. Degree Former
New York University B.S. Degree Former
Johns Hopkins University School of Medicine residency in Medicine Former

Kirby I. Bland, M.D. has served as a director of our Company since May 2004. Dr. Bland currently serves as Professor and Chairman and Fay Fletcher Kerner Professor and Chairman Department of Surgery of the University of Alabama at Birmingham (UAB) School of Medicine since 1999 and 2002, respectively, Deputy Director of the UAB Comprehensive Cancer Center since 2000 and Senior Scientist, Division of Human Gene Therapy, UAB School of Medicine since 2001. Prior to his appointments at UAB, Dr. Bland was J. Murry Breadsley Professor and Chairman, Professor of Medical Science, Department of Surgery and Director, Brown University Integrated Program in Surgery at Brown University School of Medicine from 1993 to 1999. Prior to his appointments at Brown University, Dr. Bland was Professor and Associate Chairman, Department of Surgery, University of Florida College of Medicine from 1983 to 1993 and Associate Director of Clinical Research at the University of Florida Cancer Center from 1991 to 1993. Dr. Bland held a number of medical staff positions at the University of Louisville, School of Medicine from 1977 to 1983 and at M. D. Anderson Hospital and Tumor Institute from 1976 to 1977. Dr. Bland is a member of the Board of Governors of the American College of Surgeons (ACS), a member of the ACS' Advisory Committee, Oncology Group (ACOSOG), a member of the ACS' American Joint Committee on Cancer Task Force and serves as Chairman of the ACS' Breast Disease Site Committee, COC. Dr. Bland is a past President of the Society of Surgical Oncology. Dr. Bland received his B.S. in Chemistry/Biology from Auburn University and a M.D. degree from the University of Alabama, Medical College of Alabama.

Organization Position Status
The University of Alabama at Birmingham Professor Current
The University of Alabama at Birmingham Chairman Current
Neoprobe Corporation Chairman Current
Neoprobe Corporation Director Current
The Oncology Group Board of Directors Current
The Oncology Group Member Current
Society of Surgical Oncology President Former
University of Florida Director of Clinical Research Former
University of Florida Professor Former
University of Louisville Former
University of Florida Chairman Former
The University of Alabama M.D. Degree Former
Auburn University B.S. In Chemistry, Biology Former

Gordon A. Troup, age 58, has served as a director of our company since July 2008, Mr. Troup served as President of the Nuclear Pharmacy Services business at Cardinal Health, Inc. (Cardinal), a multinational medical products and services company, from January 2003 until his retirement in December 2007. Mr. Troup joined Cardinal in 1990 and was appointed Group President of Pharmaceutical Distribution and Specialty Distribution Services in 1999. Prior to joining Cardinal Mr. Troup was employed for 10 years by American Hospital Supply Corporation and 3 years by Zellerbach Paper, a Mead Company. Mr. Troup has a B.S. degree in Business Management from San Diego State University. Mr. Troup is the member of several national healthcare trade organizations and is active in a number of not-for-profit organizations.

Organization Position Status
The Cardinal Current
Neoprobe Corporation Board of Directors Current
Cardinal Health, Inc. Executive Vice President Former
Nuclear Pharmacy Services President & Executive Vice President Former
San Diego State University B.S. Degree In Business Management Former

Organization Position Status
Neoprobe Corporation Board of Directors Current

Organization Position Status
Neoprobe Corporation Board of Directors Current
The Dow Chemical Company Director of Mergers, Acquisitions and Licensing Former

Organization Position Status
Neoprobe Corporation Board of Directors Current

Organization Position Status
Neoprobe Corporation Board of Directors Current
Ohio.Com Vice President Former
Ohio.Com Senior Medical Director of United Healthcare Former

Array

Organization Position Status
Neoprobe Corporation Board of Directors Current
Cardiosonix, Ltd. Board Member Former
John F. Kennedy School of Government M.P.A. Former
Hebrew University of Jerusalem B.A. Degrees In the History Former

Executive News

  • Neoprobe Announces Annual Meeting Results

    Reuters - 6/25/09 - View Story

advertisement
     NEOP $1.12 0.00 (0.00% )
Average Volume 82,994
Shares Outstanding 79.65M
Market Cap 89.2M
Year High 1.475
Year Low 0.35
Earnings Per Share -0.25
P/E Ratio -4.48
Dividend N/A
Yield N/A
advertisement